Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial
详细信息 查看全文
- 作者：Paul Kelly (1) (2) (3)
Tamara Shawa (2)
Stayner Mwanamakondo (2)
Rose Soko (2)
Geoff Smith (4)
G Robin Barclay (5)
Ian R Sanderson (1) - 刊名：BMC Gastroenterology
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：10
- 期：1
- 全文大小：810KB
- 参考文献：1. Thapar N, Sanderson IR:
2. Attili SVS, Gulati AK, Singh VP, Varma DV, Rai M, Sundar S:
3. Ghana VAST study team:
4. Lazzerini M, Ronfani L:
5. Tielsch JM, Khatry SK, Stoltzfus RJ, Katz J, LeClerq SC, Adhikari R, Mullany LC, Black R, Shestra S:
6. Fischer Walker CL, Black RE:
7. Irlam JH, Visser ME, Rollins N, Siegfried N:
8. Friis H:
9. Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H:
10. Burbano X, Miguez-Burbano MJ, McCollister K, Zhang G, Rodriguez A, Ruiz P, Lecusay R, Shor-Posner G:
11. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N:
12. Stephen AI, Avenell A:
13. Hughes S, Kelly P:
14. Villamor E, Fawzi WW:
15. Kelly P, Feakins R, Domizio P, Murphy J, Bevins CL, Wilson J, McPhail G, Bajaj-Elliot M, Poulsom R, Dhaliwal W:
16. Wiest R, Garcia-Tsao G:
17. Balzan S, deA Quadros C, de Cleva R, Zilberstein B, Cecconnello I:
18. Lata J, Jurankova J, Husova L, Senkyrik M, Dite P, Dastych M, Pribramska V, Kroupa R:
19. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC:
20. Gatt M, Reddy BS, Macfie J:
21. Sanderson IR, Walker WA:
22. Lake-Bakaar G, Elsakr M, Hagag N, Lyubsky S, Ahuja J, Craddock B, Steigbigel RT:
23. Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG:
24. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poulter LW:
25. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, Ullrich R:
26. Wang X, Rasmussen T, Pahar B, Poonia B, Alvarez X, Lackner AA, Veazey RS:
27. Brenchley JM, Douek DC:
28. Kelly P, Menzies I, Crane R, Zulu I, Nickols C, Feakins R, Mwansa J, Mudenda V, Katubulushi M, Greenwald S, Farthing MJG:
29. Kotler DP, Francisco A, Clayton F, Scholes JV, Orenstein JM:
30. Cummins AG, LaBrooy JT, Stanley DP, Roland R, Shearman DJC:
31. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG:
32. Kapembwa MS, Fleming SC, Sewankambo N, Serwadda D, Lucas S, Moody A, Griffin GE:
33. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, Sharpstone D, Smithson J, Menzies IS, Gazzard BG:
34. Bjarnason I, Sharpstone DR, Francis N, Marker A, Taylor C, Barrett M, Macpherson A, Baldwin C, Menzies IR, Crane RC, Smith T, Pozniak A, Gazzard BG:
35. Zulu I, Hassan G, Njobvu L, Dhaliwal W, Sianongo S, Kelly P:
36. Kelly P, Katubulushi M, Todd J, Banda R, Yambayamba V, Fwoloshi M, Zulu I, Kafwembe E, Yavwa F, Sanderson IR, Tomkins A:
37. Department of Health Report 41:
38. Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram SG, Murphy B, Jenkins AP, Crane RS, Gregory GG:
39. Stephens RC, Fidler K, Wilson P, Barclay GR, Mythen MG, Dixon GL, Turner MW, Klein NJ, Peters MJ:
40. Hamilton-Davies C, Barclay GR, Cardigan RA, McDonald SJ, Purdy G, Machin SJ, Webb AR:
41. Fernando N, Holton J, Zulu I, Vaira D, Mwaba P, Kelly P:
42. Dixon MF, Genta RM, Yardley JH, Correa P:
43. Madan E, Kemp J, Westblom TV, Subik M, Sexton S, Cook J:
44. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC:
45. Kostaki M, Fessatou S, Karpathios T:
46. Marignani M, Angeletti S, Bordi C, Malagnino F, Mancino C, Delle Fave G, Annibale B:
47. Sarker SA, Davidsson L, Mahmud H, Walczyk T, Hurrell RF, Gyr N, Fuchs G:
48. Batman PA, Miller ARO, Forster SM, Harris JRW, Pinching AJ, Griffin GE:
49. Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, Schulzke JD:
50. Batman PA, Kapembwa MS, Miller ARO, Sedgwick PM, Lucas S, Sewankando NK, Serwadda D, Pudney J, Moody A, Harris JR, Griffin GE:
51. The pre-publication history for this paper can be accessed here:ttp://www.biomedcentral.com/1471-230X/10/72/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-230X/10/72/prepub - 作者单位：Paul Kelly (1) (2) (3)
Tamara Shawa (2)
Stayner Mwanamakondo (2)
Rose Soko (2)
Geoff Smith (4)
G Robin Barclay (5)
Ian R Sanderson (1)
1. Blizard Institute of Cell and Molecular Science, Barts & The London School of Medicine, Queen Mary University of London, London, UK
2. Tropical Gastroenterology and Nutrition group, University of Zambia School of Medicine, Lusaka, Zambia
3. London School of Hygiene and Tropical Medicine, London, UK
4. Imperial College School of Medicine, Charing Cross Hospital, London, UK
5. Scottish National Blood Transfusion Service Cell Therapy Group, MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
文摘
Background Although micronutrient supplementation can reduce morbidity and mortality due to diarrhoea, nutritional influences on intestinal host defence are poorly understood. We tested the hypothesis that micronutrient supplementation can enhance barrier function of the gut. Methods We carried out two sub-studies nested within a randomised, double-blind placebo-controlled trial of daily micronutrient supplementation in an urban community in Lusaka, Zambia. In the first sub-study, gastric pH was measured in 203 participants. In the second sub-study, mucosal permeability, lipopolysaccharide (LPS) and anti-LPS antibodies, and serum soluble tumour necrosis factor receptor p55 (sTNFR55) concentrations were measured in 87 participants. Up to three stool samples were also analysed microbiologically for detection of asymptomatic intestinal infection. Gastric histology was subsequently analysed in a third subset (n = 37) to assist in interpretation of the pH data. Informed consent was obtained from all participants after a three-stage information and consent process. Results Hypochlorhydria (fasting gastric pH > 4.0) was present in 75 (37%) of participants. In multivariate analysis, HIV infection (OR 4.1; 95%CI 2.2-7.8; P < 0.001) was associated with hypochlorhydria, but taking anti-retroviral treatment (OR 0.16; 0.04-0.67; P = 0.01) and allocation to micronutrient supplementation (OR 0.53; 0.28-0.99; P < 0.05) were protective. Hypochlorhydria was associated with increased risk of salmonellosis. Mild (grade 1) gastric atrophy was found in 5 participants, irrespective of Helicobacter pylori or HIV status. Intestinal permeability, LPS concentrations in serum, anti-LPS IgG, and sTNFR55 concentrations did not differ significantly between micronutrient and placebo groups. Anti-LPS IgM was reduced in the micronutrient recipients (P <0.05). Conclusions We found evidence of a specific effect of HIV on gastric pH which was readily reversed by anti-retroviral therapy and not mediated by gastric atrophy. Micronutrients had a modest impact on gastric pH and one marker of bacterial translocation. Trial Registration Current Controlled Trials ISRCTN31173864